Skip to main content
AVIR logo

AVIR · Atea Pharmaceuticals, Inc. · Proposed Sales

Track AVIR — free
$3.96 +0.03 (+0.76%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$318.00M
Shares
80.30M
Volume · Nov 20 416.47K Avg daily vol (3M) 289.48K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-11-19 BRUNO LUCIDI 22,619
2026-11-19 BRUCE POLSKY 8,750
2026-11-18 BRUCE POLSKY 18,252
2026-11-17 BRUNO LUCIDI 6,741
2026-11-17 BRUCE POLSKY 8,720
2026-11-16 BRUCE POLSKY 14,254
2024-12-10 Franklin Berger 359,606
2024-09-19 JPM Partners LLC 1,841
2024-09-18 JPM Partners LLC 22,187
2024-09-17 JPM Partners LLC 33,941
2024-06-20 Polsky Bruce 17,544
2024-06-05 JPM Partners LLC 1,006
2024-02-01 Jean-Pierre Sommadossi 65,476
2024-02-01 Wayne Foster 14,311
2024-02-01 Maria Arantxa Horga 18,227
2024-02-01 John Vavricka 13,552
2024-02-01 Janet MJ Hammond 16,110
2024-02-01 Andrea Corcoran 18,198
Showing 1–18 of 18 filings
Key facts CIK 1593899 CUSIP 04683R106 13F (30d) 135 filings 118 filers Visit website Investor relations